These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 35011517
1. Biophysical Characterization of Novel DNA Aptamers against K103N/Y181C Double Mutant HIV-1 Reverse Transcriptase. Ratanabunyong S, Seetaha S, Hannongbua S, Yanaka S, Yagi-Utsumi M, Kato K, Paemanee A, Choowongkomon K. Molecules; 2022 Jan 03; 27(1):. PubMed ID: 35011517 [Abstract] [Full Text] [Related]
2. Use of Capillary Electrophoresis to Study the Binding Interaction of Aptamers with Wild-Type, K103N, and Double Mutant (K103N/Y181C) HIV-1 RT : Studying the Binding Interaction of Wild-Type, K103N, and Double Mutant (K103N/Y181C) HIV-1 RT with Aptamers by Performing the Capillary Electrophoresis. Aeksiri N, Warakulwit C, Hannongbua S, Unajak S, Choowongkomon K. Appl Biochem Biotechnol; 2017 Jun 03; 182(2):546-558. PubMed ID: 27900665 [Abstract] [Full Text] [Related]
6. Novel indolylarylsulfone derivatives as covalent HIV-1 reverse transcriptase inhibitors specifically targeting the drug-resistant mutant Y181C. Gao P, Song S, Frutos-Beltrán E, Li W, Sun B, Kang D, Zou J, Zhang J, Pannecouque C, De Clercq E, Menéndez-Arias L, Zhan P, Liu X. Bioorg Med Chem; 2021 Jan 15; 30():115927. PubMed ID: 33352387 [Abstract] [Full Text] [Related]
13. Effect of a bound non-nucleoside RT inhibitor on the dynamics of wild-type and mutant HIV-1 reverse transcriptase. Zhou Z, Madrid M, Evanseck JD, Madura JD. J Am Chem Soc; 2005 Dec 14; 127(49):17253-60. PubMed ID: 16332074 [Abstract] [Full Text] [Related]
16. HIV-1 reverse transcriptase (RT) polymorphism 172K suppresses the effect of clinically relevant drug resistance mutations to both nucleoside and non-nucleoside RT inhibitors. Hachiya A, Marchand B, Kirby KA, Michailidis E, Tu X, Palczewski K, Ong YT, Li Z, Griffin DT, Schuckmann MM, Tanuma J, Oka S, Singh K, Kodama EN, Sarafianos SG. J Biol Chem; 2012 Aug 24; 287(35):29988-99. PubMed ID: 22761416 [Abstract] [Full Text] [Related]
17. Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment). Joshi P, Prasad VR. J Virol; 2002 Jul 24; 76(13):6545-57. PubMed ID: 12050367 [Abstract] [Full Text] [Related]
19. 4-Benzyl and 4-benzoyl-3-dimethylaminopyridin-2(1H)-ones: in vitro evaluation of new C-3-amino-substituted and C-5,6-alkyl-substituted analogues against clinically important HIV mutant strains. Benjahad A, Croisy M, Monneret C, Bisagni E, Mabire D, Coupa S, Poncelet A, Csoka I, Guillemont J, Meyer C, Andries K, Pauwels R, de Béthune MP, Himmel DM, Das K, Arnold E, Nguyen CH, Grierson DS. J Med Chem; 2005 Mar 24; 48(6):1948-64. PubMed ID: 15771439 [Abstract] [Full Text] [Related]
20. Identification of novel bifunctional HIV-1 reverse transcriptase inhibitors. Lai MT, Tawa P, Auger A, Wang D, Su HP, Yan Y, Hazuda DJ, Miller MD, Asante-Appiah E, Melnyk RA. J Antimicrob Chemother; 2018 Jan 01; 73(1):109-117. PubMed ID: 29029095 [Abstract] [Full Text] [Related] Page: [Next] [New Search]